MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-15-2294

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2015

Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.

Rothermel Luke D, Sabesan Arvind C, Stephens Daniel J, Chandran Smita S, Paria Biman C, Srivastava Abhishek K, Somerville Robert, Wunderlich John R, Lee Chyi-Chia R, Xi Liqiang, Pham Trinh H, Raffeld Mark, Jailwala Parthav, Kasoji Manjula, Kammula Udai S

СтатьяResearch Support, N.I.H., IntramuralПеревод пока не подготовлен

Аннотация

PURPOSE: Uveal melanoma is a rare melanoma variant with no effective therapies once metastases develop. Although durable cancer regression can be achieved in metastatic cutaneous melanoma with immunotherapies that augment naturally existing antitumor T-cell responses, the role of these treatments for metastatic uveal melanoma remains unclear. We sought to define the relative immunogenicity of these two melanoma variants and determine whether endogenous antitumor immune responses exist against uveal melanoma.

EXPERIMENTAL

DESIGN

We surgically procured liver metastases from uveal melanoma (n = 16) and cutaneous melanoma (n = 35) patients and compared the attributes of their respective tumor cell populations and their infiltrating T cells (TIL) using clinical radiology, histopathology, immune assays, and whole-exomic sequencing.

RESULTS

Despite having common melanocytic lineage, uveal melanoma and cutaneous melanoma metastases differed in their melanin content, tumor differentiation antigen expression, and somatic mutational profile. Immunologic analysis of TIL cultures expanded from these divergent forms of melanoma revealed cutaneous melanoma TIL were predominantly composed of CD8(+) T cells, whereas uveal melanoma TIL were CD4(+) dominant. Reactivity against autologous tumor was significantly greater in cutaneous melanoma TIL compared with uveal melanoma TIL. However, we identified TIL from a subset of uveal melanoma patients which had robust antitumor reactivity comparable in magnitude with cutaneous melanoma TIL. Interestingly, the absence of melanin pigmentation in the parental tumor strongly correlated with the generation of highly reactive uveal melanoma TIL.

CONCLUSIONS

The discovery of this immunogenic group of uveal melanoma metastases should prompt clinical efforts to determine whether patients who harbor these unique tumors can benefit from immunotherapies that exploit endogenous antitumor T-cell populations. Clin Cancer Res; 22(9); 2237-49. ©2015 AACR.

Для цитирования: Rothermel Luke D, Sabesan Arvind C, Stephens Daniel J, Chandran Smita S, Paria Biman C, Srivastava Abhishek K, Somerville Robert, Wunderlich John R, Lee Chyi-Chia R, Xi Liqiang, Pham Trinh H, Raffeld Mark, Jailwala Parthav, Kasoji Manjula, Kammula Udai S. Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015. DOI: 10.1158/1078-0432.ccr-15-2294.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.